Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Trial of implantable contact lenses expanded

This article was originally published in Clinica

Executive Summary

Staar Surgical is to begin Phase III clinical trials in the US of its implantable contact lenses (ICLs) for myopia after getting the go-ahead from the FDA. The Monrovia, California-based company will implant 278 additional ICL's in patients and expand its trials to include patients with myopia of three dioptres.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT082462

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel